-+ 0.00%
-+ 0.00%
-+ 0.00%

BioNxt secures Europe, Eurasia patents for cladribine thin-film technology

PUBT·08/17/2026 10:40:15
Listen to the news
BioNxt secures Europe, Eurasia patents for cladribine thin-film technology
  • BioNxt reported patent grants in Europe and Eurasia covering its core cladribine sublingual thin-film drug-delivery technology.
  • The US patent application remains under USPTO Track One prioritized examination, as the company builds broader international protection.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNxt Solutions Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608170640ACCESSWRNAPR_____1208015) on August 17, 2026, and is solely responsible for the information contained therein.